People moves: Alkermes and Euro RSCG Life UK

Share this article:
Alkermes hired Mark Stejbach as its first chief commercial officer. Stejbach will oversee the biotech firm's commercial activities, including marketing alcohol-addiction drug Vivitrol and, potentially, several pipeline projects. Stejbach recently held the same post at Tenjion, which focuses on regenerative medicine. He also served as Merck's VP of managed care marketing from 2005 to 2008.

Havas Worldwide Health's Euro RSCG Life UK made three senior appointments to its London-based team, in addition to bringing nine new executives on board. The senior appointments are Dr. Vernon Baiton as medical director, Jenny Plant as client services director, and Paul Delboy as SVP, director of operations Europe for Havas Worldwide Health. Baiton comes to Euro from Sudler & Hennessey, where he served as UK medical director for its medical communications business unit. Plant, who will oversee all account teams, has held similar roles at Publicis Life Brands and S&H. Delboy will oversee all day-to-day operations and production services for the two Havas agency networks Euro RSCG Life and Health 4 Brands.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in People Moves

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves: October 20

Promotions and hires for agencies and manufacturers

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media